AARS2 Gene Leukoencephalopathy Progressive with Ovarian Failure NGS Genetic DNA Test
Comprehensive Genetic Analysis for Neurological and Reproductive Health
The AARS2 Gene Leukoencephalopathy Progressive with Ovarian Failure NGS Genetic DNA Test represents a breakthrough in precision medicine, offering comprehensive genetic screening for individuals at risk of developing this rare but serious neurological condition. This advanced diagnostic tool utilizes state-of-the-art Next-Generation Sequencing technology to detect mutations in the AARS2 gene, providing critical insights for early intervention and personalized treatment strategies.
What Does This Test Measure and Detect?
This sophisticated genetic test specifically targets the AARS2 gene, which encodes alanyl-tRNA synthetase 2, a mitochondrial enzyme essential for protein synthesis. The test identifies:
- Pathogenic variants in the AARS2 gene associated with leukoencephalopathy
- Specific mutations linked to progressive neurological deterioration
- Genetic markers connected to premature ovarian failure
- Inheritance patterns for family planning decisions
- Risk assessment for future generations
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals experiencing:
- Progressive neurological symptoms including motor coordination difficulties
- Cognitive decline or developmental regression
- Premature ovarian failure before age 40
- Family history of neurological disorders
- Unexplained white matter abnormalities on brain imaging
- Reproductive health concerns with neurological symptoms
- Women experiencing early menopause with neurological manifestations
Clinical Benefits of AARS2 Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Early Diagnosis: Enables prompt intervention before significant neurological damage occurs
- Personalized Treatment: Guides targeted therapeutic approaches based on genetic profile
- Reproductive Planning: Informs family planning decisions and genetic counseling
- Prognostic Information: Helps predict disease progression and expected outcomes
- Family Risk Assessment: Identifies at-risk relatives for preventive monitoring
- Research Contribution: Advances understanding of rare genetic disorders
Understanding Your Test Results
Our comprehensive genetic counseling services help you interpret your results accurately:
- Positive Result: Indicates presence of AARS2 gene mutation, requiring specialized neurological and reproductive care
- Negative Result: Suggests absence of tested mutations, though continued monitoring may be recommended
- Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation
- Carrier Status: Important information for family planning and genetic counseling
Test Pricing and Details
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
| Turnaround Time | 3-4 Weeks |
| Sample Type | Blood |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.
Take Control of Your Neurological Health
Don’t wait to get the answers you need for proper diagnosis and treatment planning. Our experienced genetic counselors and neurological specialists are ready to guide you through the testing process and help you understand your results.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your AARS2 Gene Leukoencephalopathy Progressive with Ovarian Failure NGS Genetic DNA Test and take the first step toward comprehensive neurological and reproductive health management.
